Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cigna Corp (NY:CI)

319.75 -0.64 (-0.20%)
Official Closing Price Updated: 5:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cigna Corp

< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
Via Benzinga
How Is The Market Feeling About Cigna Group?
Via Benzinga
Jim Cramer On Centene's 40% Crash: Fewer ACA Signups, Sicker Patients, Pulled Guidance And Major Earnings Hit Trigger Selloff: 'This Is Horrifying'
Shares of managed care provider Centene Corp. (NYSE: CNC) dropped over 40% on Wednesday, marking the worst single-day performance in the company's history. 
Via Benzinga
Amazon Wants More Power
Amazon's latest data center will reportedly require the same amount of electricity as 1 million homes. 
Via The Motley Fool
Topics Artificial Intelligence
How Is The Market Feeling About Cigna Group?
Via Benzinga
Here's How Much $100 Invested In Cigna Group 15 Years Ago Would Be Worth Today
Via Benzinga
1 S&P 500 Stock Worth Your Attention and 2 to Steer Clear Of
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth,... 
Via StockStory
Topics Stocks
5 Insightful Analyst Questions From Cigna’s Q1 Earnings Call
Cigna’s first-quarter results surpassed Wall Street’s revenue and non-GAAP profit expectations, with management highlighting strong performance from the company’s specialty pharmacy and pharmacy... 
Via StockStory
Topics Earnings World Trade
Thursday's session: top gainers and losers in the S&P500 index
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session. 
Via Chartmill
Senate Republicans’ Medicaid Cuts Threaten To Put Trump’s ‘Big, Beautiful Bill’ In Jeopardy Ahead Of Vote
The provisions at risk include the plan to hold down Medicaid costs by cracking down on a state provider tax. 
Via Stocktwits
Topics Government
Bristol Myers Faces Scrutiny For Allegedly Rigging Market On $2B Cancer Drug
Bristol Myers and Celgene are being sued in an antitrust suit, alleging they used fraud, sham litigation, and reverse payments to delay cheaper generics of Pomalyst. 
Via Benzinga
Topics Fraud Lawsuit
Here's How Much $100 Invested In Cigna Group 15 Years Ago Would Be Worth Today
Via Benzinga
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'
A debate over the healthcare system erupted on X, pitting Mark Cuban against Elizabeth Warren over the root causes of soaring drug prices. 
Via Benzinga
UnitedHealth Stock Touted For 36% Gain? JPMorgan Points To Medicare Advantage Margin Tailwind
The research firm expects lower enrollment growth as UnitedHealth exits unprofitable plans and prioritizes margin discipline. 
Via Stocktwits
Topics Government
Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q1 Earnings?
Abbott Laboratories has had an impressive run over the past six months. While the S&P 500 has been flat, the stock has returned 17.8% and now trades at $133.43. This performance may have investors... 
Via StockStory
Topics Stocks Supply Chain
Senate Bill Tightens Medicaid Rules: Humana, Cigna, CVS See Medicare Relief
The draft Senate bill introduces stricter work requirements and funding curbs for Medicaid, while shelving proposed Medicare cuts that could have impacted major insurers. 
Via Stocktwits
Topics Government
Q1 Earnings Highs And Lows: Cigna (NYSE:CI) Vs The Rest Of The Health Insurance Providers Stocks
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Cigna (NYSE:CI) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
1 Safe-and-Steady Stock with Promising Prospects and 2 to Avoid
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
2 Reasons to Like CI and 1 to Stay Skeptical
Cigna trades at $313 per share and has moved almost in lockstep with the market over the last six months. The stock has lost 7.3% while the S&P 500 is down 2.5%. This may have investors wondering how... 
Via StockStory
Topics Stocks Supply Chain
"If Walmart Is Under Pressure to Raise Prices, It's Going to Have Broader Effects on the Economy."
Via The Motley Fool
Topics Earnings Economy World Trade
Microsoft Clears Major Hurdle As FTC Ends Effort To Block Activision Merger
The Ninth Circuit affirmed a decision denying the FTC's application to block Microsoft's acquisition of Activision Blizzard. The FTC dropped the case and Trump's personnel changes may impact future... 
Via Benzinga
Topics Government
FTC Scraps PepsiCo Price Discrimination Case In 3-0 Vote, Marking Major Shift As Trump-Era Leadership Reverses Biden Crackdown
The Federal Trade Commission voted 3-0 Thursday to dismiss a lawsuit against PepsiCo Inc. that accused the beverage giant of offering preferential pricing to major retailers, marking a significant... 
Via Benzinga
Topics Government Lawsuit
Why Hims & Hers Health (HIMS) Stock Is Falling Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.3% in the afternoon session after Cigna Group's Evernorth division introduced a monthly $200 price cap for weight-loss medications... 
Via StockStory
Topics Artificial Intelligence
Hims & Hers Stock Drops After Evernorth Announces Cheaper Pricing For Weight-Loss Drugs: Retail’s Dull
Truist noted on Thursday that the $200/month price point is "highly attractive compared to other price points in the market," including Hims & Hers' compounded Semaglutide, Wegovy, and Liraglutide... 
Via Stocktwits
Wegovy, Zepbound Just Got Cheaper: Cigna Sets $200 Monthly Limit For Weight-Loss Drug Users
Cigna’s Evernorth has reached agreements with Eli Lilly and Novo Nordisk to reduce prices for GLP-1 weight-loss drugs Wegovy and Zepbound 
Via Stocktwits
Humana, UnitedHealth, CVS Slide As CMS Targets Medicare Overpayments In ‘Aggressive’ Audit Plan
US healthcare stocks came under pressure after CMS said it would expand Medicare Advantage audits and partner with the HHS Inspector General to recover past overpayments. 
Via Stocktwits
Here's How Much You Would Have Made Owning Cigna Group Stock In The Last 20 Years
Via Benzinga
What's going on in today's pre-market session: S&P500 movers
Get insights into the top gainers and losers in the S&P500 index of Tuesday's pre-market session. 
Via Chartmill
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion
Trump signed an executive order to lower drug prices, which could hit pharmacy benefit managers (PBMs) hard. PBMs have come under scrutiny for opaque pricing practices. Mark Cuban calls PBMs a racket. 
Via Benzinga
Topics Government
Discover which S&P500 stocks are making waves on Friday.
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Friday as we examine the latest happenings in today's session. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.